These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8422019)

  • 1. Inosithin neutralization test to measure lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1993 Jan; 99(1):61-4. PubMed ID: 8422019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
    Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN
    Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.
    Dragoni F; Minotti C; Palumbo G; Faillace F; Redi R; Bongarzoni V; Avvisati G
    Thromb Res; 2001 Jan; 101(2):45-51. PubMed ID: 11342205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaolin clotting time.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():335-9. PubMed ID: 23546725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants.
    Reber G; Roisin JP; Migaud M; de Moerloose P
    Thromb Res; 1994 Jan; 73(2):131-5. PubMed ID: 8171412
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet neutralization test.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():349-51. PubMed ID: 23546727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of several laboratory tests and test combinations in the detection of lupus anticoagulant.
    Legnani C; Palareti G; Boggian O; Cavallaroni K; Oca G; Lo Manto G; Abate C; Coccheri S
    Int J Clin Lab Res; 1992; 22(2):106-10. PubMed ID: 1504302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria.
    Awodu OA; Ejele OA; Shokunbi WA; Enosolease ME
    Niger Postgrad Med J; 2003 Mar; 10(1):19-22. PubMed ID: 12812147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).
    Tripodi A; Chantarangkul V
    Methods Mol Biol; 2017; 1646():177-183. PubMed ID: 28804829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Activated Partial Thromboplastin Time: Difficulties in Discriminating Coexistent Factor VIII Inhibitor and Lupus Anticoagulant.
    Ames PR; Graf M; Archer J; Scarpato N; Iannaccone L
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):149-54. PubMed ID: 24989713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicohematologic spectrum in patients with lupus anticoagulant.
    Bhattacharya M; Biswas A; Kannan M; Mishra P; Kumar A; Choudhry VP; Saxena R
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):191-5. PubMed ID: 15821825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations.
    Rosove MH; Ismail M; Koziol BJ; Runge A; Kasper CK
    Blood; 1986 Aug; 68(2):472-8. PubMed ID: 3730611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
    Triplett DA; Barna LK; Unger GA
    Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
    Ghafouri S; Rettig M; Kahlon KS
    Am J Case Rep; 2020 Oct; 21():e926728. PubMed ID: 33122620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation abnormalities in systemic lupus erythematosus.
    Saraya AK; Rai R; Saxena R; Singh RR; Padmakumar K; Malaviya AN
    Indian J Med Res; 1989 Oct; 90():335-40. PubMed ID: 2628301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
    Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F
    J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.